The World Trade Organisation (WTO) Secretariat has issued an indicative list of trade-related bottlenecks and trade-facilitating measures on critical products to combat COVID-19.
These includes inputs used in vaccine manufacturing, vaccine distribution and approval, therapeutics and pharmaceuticals, diagnostics and medical devices.
The list released in advance of a High-Level Dialogue by the World Health Organisation (WHO) and the WTO today on expanding COVID-19 vaccines manufacturing to promote equitable access.
The indicative list was based on issues identified and suggestions made by speakers at the WTO webinar Regulatory Cooperation during the COVID-19 Pandemic, in June, and the WTO symposium COVID-19 Vaccine Supply Chain and Regulatory Transparency, on June 29, 2021.